Cardio-Cor Has Success in Completing First Phase of Clinical Trials


LAS VEGAS, Nov. 13, 2008 (GLOBE NEWSWIRE) -- Cardio Infrared Technologies, Inc. (Pink Sheets:CIRT), www.cardio-cor.com, a leading Health and Wellness technology and marketing company, announced today they have successfully completed the first phase, the efficacy portion, of the clinical trials being conducted in Pennsylvania.

Wayne Bailey, President and CEO of Cardio Infrared Technologies, Inc., stated, "The first phase of the clinical trials has been successfully completed; this is the efficacy portion of the trials. The trials will confirm the question: does the equipment work in helping to lose weight, inches, and cellulite? The initial results were compiled and have been sent to the attorney for FTC review. The report will be complete in approximately two weeks and will be posted on the Cardio-Cor website. We fully expect the report to show that the Cardio-Cor works in reduction of inches and weight. The trials are being expanded based on this initial report that the Cardio-Cor does in fact help reduce inches and weight. These trials were conducted with the subjects making no other change in their life style or eating habits."

The Cardio-Cor is designed to help detoxify the body and enhance the metabolism. Detoxification is at the heart of the Cardio-Cor. Today more than 3,000 chemicals are added to our food supply. More than 10,000 chemicals in the form of solvents, emulsifiers and preservatives are used in food processing and storage. When ingested, these chemicals can remain in the body for years, altering our metabolism, causing enzyme dysfunction and nutritional deficiencies, creating hormonal imbalances and lowering our threshold of resistance to chronic disease. Cardio-Cor will soon be releasing new products to assist in managing nutritional Health and Wellness.

Many of the current locations of the Cardio-Cor are using some nutritional programs and are seeing a major difference in the amount of inches and weight loss with their customers. The second phase of the ongoing clinical trials will be expected to show the detoxification benefits of the Cardio-Cor when used in conjunction with a proper nutritional regimen.

About Cardio Infrared Technologies, Inc.

Cardio Infrared Technologies, Inc. is a technology and marketing company, which is focused on developing the revolutionary and evolutionary process of combining exercise equipment with medical benefits that go far beyond the normal benefits of standard exercise equipment. Cardio Infrared Technologies, Inc. is committed to continue to market this equipment to the exercise and medical markets and to aggressively expand the market to every country around the world. The equipment has already been featured on Good Morning America and The View. Cardio Infrared Technologies, Inc. also has an aggressive growth plan that includes acquisitions and development of innovative new equipment and programs in the exercise and medical industries.

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words or phrases "would be," "would allow," "intends to" "will likely result," "are expected to," "will continue," "anticipate," "expect," "estimate," "project," "indicate," "could," "potentially," "should," "believe," "considers," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. These include the company's historic lack of profitability, end user customer acceptance and actual demand, which may differ significantly from expectations, the need for the company to manage its growth, the need to raise funds for operations and other risks within the regulation of the industry. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, events or circumstances after the date of such statement.



            

Tags


Contact Data